Mana.bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 8

Mana.bio General Information

Description

Operator of an artificial intelligence-based drug delivery company intended to facilitate lipid nanoparticle development for oligonucleotide therapies. The company uses technology powered by the integration of machine learning and nanotechnology to identify formulations of lipid nanoparticle systems and focus on gene therapy, including DNA and RNA-based therapeutics, and vaccines, enabling the healthcare industry to get a better drug delivery service.

Contact Information

Website
www.mana.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Hamelacha Street
  • Tel Aviv 6721502
  • Israel
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Nanotechnology, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 2 Hamelacha Street
  • Tel Aviv 6721502
  • Israel

Mana.bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mana.bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 04-Sep-2025 Completed Generating Revenue
2. Seed Round 10-Oct-2023 Completed Generating Revenue
1. Seed Round 18-Oct-2021 $5M $5M Completed Generating Revenue
To view Mana.bio’s complete valuation and funding history, request access »

Mana.bio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 1
Seed 2
To view Mana.bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Mana.bio Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 10

    Pending

  • Expiring in next 12 mo

Mana.bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026190787-A1 Lipid nanoparticles and use thereof for targeting t-cells Pending 13-Mar-2025
WO-2026190788-A1 Lipid nanoparticles and use thereof for targeting t-cells Pending 13-Mar-2025
WO-2026120590-A1 Ionizable lipids and nanoparticles comprising same Pending 02-Dec-2024
WO-2026120592-A1 Lipid nanoparticles and use thereof for lung targeting Pending 02-Dec-2024
EP-4648802-A1 Ionizable lipids and nanoparticles comprising same Pending 09-Jan-2023 A61K31/7105
To view Mana.bio’s complete patent history, request access »

Mana.bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mana.bio Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gaingels Venture Capital Minority
Neman Ventures Venture Capital Minority
Andreessen Horowitz Venture Capital Minority
Base4 Capital Hedge Fund Minority
Old Silver VC Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Mana.bio FAQs

  • When was Mana.bio founded?

    Mana.bio was founded in 2021.

  • Where is Mana.bio headquartered?

    Mana.bio is headquartered in Tel Aviv, Israel.

  • What is the size of Mana.bio?

    Mana.bio has 20 total employees.

  • What industry is Mana.bio in?

    Mana.bio’s primary industry is Drug Delivery.

  • Is Mana.bio a private or public company?

    Mana.bio is a Private company.

  • What is Mana.bio’s current revenue?

    The current revenue for Mana.bio is .

  • How much funding has Mana.bio raised over time?

    Mana.bio has raised $19.5M.

  • Who are Mana.bio’s investors?

    Gaingels, Neman Ventures, Andreessen Horowitz, Base4 Capital, and Old Silver VC are 5 of 8 investors who have invested in Mana.bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process